Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
Clinical trial NCT05773326 · TERMINATED
Trial details
- NCT number
- NCT05773326
- Sponsor
- Nader Sanai
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2025-02-28
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.